Session 23
Evolving Concepts in Dermatology Part XX
- About
- Faculty
- Learning Objectives
- Intended Audience
- Accreditation Statement
- Credit Designation Statement
- Disclosure
- Disclaimer
FCVGR will consist of weekly CME sessions on a variety of dermatological diseases and tools.
This week, we will be coming to you LIVE!
Wednesday, December 16, 2020
8 PM EST/ 5 PM PST
8:00 PM EST: Therapeutic Update (Non-CME)
New Information and Updated Prescribing Information for A Novel Oral Antibiotic
8:30 PM EST EVOLVING CONCEPTS IN DERMATOLOGY PART XX (CME)
FC20 Encore. Your Top Questions Answered.
Andrew Alexis, MD, MPH
Faculty
Chairman
Mount Sinai St. Luke’s and Mount Sinai West
New York, New York
Neal Bhatia, MD
Faculty
Director of Clinical Dermatology
Therapeutics Clinical Research
San Diego, California
James Del Rosso, DO
Moderator
Adjunct Clinical Professor (Dermatology)
Touro University College of Osteopathic Medicine
Henderson, NV
Alexandra Golant, MD FAAD
Faculty
Medical Director, Dermatology Faculty Practice
Associate Director, Residency Program
Kimberly and Eric J. Waldman Department of Dermatology
Icahn School of Medicine at Mount Sinai
New York, NY
Gary Goldenberg, MD
Faculty
Assistant Clinical Professor of Dermatology
Icahn School of Medicine at Mount Sinai
New York, NY
Brett King, MD, PhD
Faculty
Associate Professor of Dermatology
Yale School of Medicine
New Haven, CT
Mark Lebwohl, MD
Faculty
Dean for Clinical Therapeutics
Waldman Professor and Chairman
Kimberly and Eric J. Waldman Department of Dermatology
Icahn School of Medicine at Mount Sinai
New York, NY
Upon completion of this activity, the participant should be better able to:
- Apply new knowledge and clinical pearls that can be immediately incorporated in clinical settings
- Integrate new treatment options and techniques for treating patients with a variety of dermatologic conditions
- Discuss the latest clinical data to evaluate the optimal use of therapies for your patients
This activity is supported by an educational grant from Almirall.
CONFLICTS OF INTEREST/DISCLOSURES
Andrew F. Alexis, MD, MPH
Grant/Research Support: Leo, Novartis, Almirall, BMS, Celgene, Menlo, Galderma, Valeant (Bausch Health), Cara
Consultant: SELF: Leo, Novartis, Menlo, Galderma, Pfizer, SGR, Dermavant, Unilever, Celgene, Beiersdorf, Valeant, L’Oreal, BMS, Scientis, Bausch Health, UCB, Foamix, Cassiopea
Royalty: Springer, Wiley-Blackwell, Wolters Kluwer (UpToDate)
James Q. Del Rosso, DO
Grant/Research Support: Aclaris, Almirall, Amgen(Celgene), Anaptyso Bio, Arcutis, Athenex, Bausch (Ortho Dermatologics), Biopharmx, Biorasi, Botanix, Cara Therapeutics, Cassiopea, EPI Health, Foamix/Menlo, Galderma, Genentech, Incyte, Leo, Lilly (Dermira), Novan, Pfizer, Ralexar, Sanofi Genzyme Regeneron, SolGel, SUN
Consultant: Aclaris, Almirall, Bausch (Ortho Dermatologics) Biofrontera, Biopharmx, Cassiopea, Encore, EPI Health, Ferndale, Foamix/Menlo, Galderma, Leo, LaRoche Posay, Lilly (Dermira), MC2, Novan, Pfizer, Sanofi Genzyme Regeneron, SolGel, Sonoma(Intraderm), SUN, Verrica
Speakers’ Bureau or Honoraria: Aclaris, Almirall, Bausch (Ortho Dermatologics), Biofrontera, EPI Health, Ferndale, Galderma, Genentech, Leo, Lilly (Dermira), Pfizer, Sanofi Genzyme Regeneron, SUN, Verrica
Alexandra K. Golant, MD
Consultant: Novartis, Abbvie, Lilly, UCB
Speakers’ Bureau or Honoraria: Sanofi Genzyme Regeneron, Ortho Dermatologics
Gary Goldenberg, MD
Consultant: Abbvie, Allergan, Amgen, ALMA, Almirall, Bayer, Castle Biosciences, Celgene, Dermira, Eclipse, Galderma, Genentech, GSK/Stiefel, Intraderm, ISDIN, Janssen, Leo, Menlo, Novartis, Pharaderm, Pfizer, Ranbaxy, Regeneron/Sanofi, Scibase, Suneva, TEVA, Valeant/Ortho Dermatologic, Verrica
Speakers’ Bureau or Honoraria: Abbvie, ALMA, Bayer, Celgene, Dermira, Leo, Merz, Novartis, Pharmaderm, Pfizer, Regeneron/Sanofi
Other Financial Benefit: BOD-Verrica
Mark Lebwohl, MD
Grant/Research Support: Abbvie, Amgen, Arcutis, Boehringer-Ingelheim, Dermavant, Lilly, Incyte, Janssen, Leo, Ortho Dermatologics, Pfizer, UCB
Consultant: Aditum Bio, Allergan, Almirall, Arcutis, Avotres Therapeutics, BirchBioMed, BMD Skincare, Boehringer-Ingelheim, BMS, Cara Therapeutics, Castle Biosciences, Corrona, Dermavant, EMD Serono, Evelo Biosciences, Facilitation of International Dermatology Education, Foundation for Research and Education in Dermatology, Helsinn Therapeutics, Inozyme Pharma, Kyowa Kirin, Leo, Meiji Seika Pharma, Menlo, Neuroderm, Pfizer, Promius/ Dr. Reddy’s Labs, Theravance, Verrica
Cathy Pagano (Institute for Continuing Healthcare Education) has disclosed that she has no relevant financial relationships specific to the subject matter within the past 12 months.